This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Essential cookies enable basic functions and are necessary for the website to function properly.
Statistics cookies collect information anonymously. This information helps us to understand how our visitors use our website.
Marketing cookies are used by third parties or publishers to display personalized advertisements. They do this by tracking visitors across websites.

ITM Precision Oncology Symposium 2021

Ancillary Event in parallel to 2021 ASCO Annual Meeting

Thank you for your interest in ITM’s Precision Oncology Symposium 2021.

A recording of the symposium and the ensuing discussion is available to Healthcare Professionals here:

View full recording  View compilation

 

Scientific Program


Chair: Richard L Wahl, MD
Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, U.S.

Welcome & Introduction
Richard L Wahl, MD, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, U.S.

The potential for state-of-the-art Targeted Radionuclide Therapy & Diagnostics and future applications
Richard L Wahl, MD, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, U.S. (15 min)

The clinical management of NETs – a multi-disciplinary team approach
Jennifer A Chan, MD, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, U.S. (15 min)

Leveraging the latest developments in somatostatin receptor-positive tumors to generate novel therapeutic opportunities
Thorvardur R Halfdanarson, MD, Mayo Clinic, Rochester, MN, U.S. (15 min)

ITM’s precision oncology pipeline
Mona M Wahba, MD, MSM, ITM, Munich, Germany (15 min)

Discussion & Closing Remarks

Program for Download